These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27314831)

  • 21. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of APC gene promoter methylation and the risk of gastric cancer: A meta-analysis and bioinformatics study.
    Zhou X; Jiao D; Dou M; Zhang W; Hua H; Chen J; Li Z; Li L; Han X
    Medicine (Baltimore); 2020 Apr; 99(16):e19828. PubMed ID: 32312003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies.
    Li L; Gan Y; Wu C; Qu X; Sun G; Lu Z
    BMC Cancer; 2015 Oct; 15():733. PubMed ID: 26481317
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Guo Y; Liu W; Wu J
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C229-C232. PubMed ID: 28230023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors.
    Wild A; Ramaswamy A; Langer P; Celik I; Fendrich V; Chaloupka B; Simon B; Bartsch DK
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1367-73. PubMed ID: 12629131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
    Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis.
    Yan J; Wang X; Tao H; Yang W; Luo M; Lin F
    Obes Res Clin Pract; 2015; 9(4):389-97. PubMed ID: 25733497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between p16 Promoter Methylation and Thyroid Cancer Risk: A Meta-analysis.
    Wu W; Yang SF; Liu FF; Zhang JH
    Asian Pac J Cancer Prev; 2015; 16(16):7111-5. PubMed ID: 26514498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies.
    Xiao X; Cai F; Niu X; Shi H; Zhong Y
    PLoS One; 2016; 11(9):e0163257. PubMed ID: 27648827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma.
    Shen B; Jiang Y; Chen YR; Zheng HC; Zeng W; Li YY; Yin A; Nie Y
    Oncol Rep; 2016 Jul; 36(1):494-502. PubMed ID: 27222429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
    Liu F; Lu X; Zhou X; Huang H
    Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Runt-related Transcription Factor 3 Promoter Hypermethylation and Gastric Cancer Risk: A Meta-analysis.
    Lina M; Changan W; Qing Z
    Open Life Sci; 2018 Jan; 13():64-70. PubMed ID: 33817069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis.
    Darnton SJ; Hardie LJ; Muc RS; Wild CP; Casson AG
    Int J Cancer; 2005 Jun; 115(3):351-8. PubMed ID: 15688381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.
    To KF; Leung WK; Lee TL; Yu J; Tong JH; Chan MW; Ng EK; Chung SC; Sung JJ
    Int J Cancer; 2002 Dec; 102(6):623-8. PubMed ID: 12448005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter methylation of human mutL homolog 1 and colorectal cancer risk: A meta-analysis.
    Shi B; Chu J; Gao Q; Tian T
    J Cancer Res Ther; 2018; 14(4):851-855. PubMed ID: 29970664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between
    Zhou K; Cai C; He Y; Zhou C; Zhao S; Ding X; Duan S
    DNA Cell Biol; 2019 Oct; 38(10):1147-1154. PubMed ID: 31453724
    [No Abstract]   [Full Text] [Related]  

  • 39. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
    Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis.
    Meng RW; Li YC; Chen X; Huang YX; Shi H; Du DD; Niu X; Lu C; Lu MX
    Sci Rep; 2016 Feb; 6():20756. PubMed ID: 26857374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.